About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« The Effect of Foreign Generics on the U.S. Drug Supply - Part III | Main | Ex parte Kubin (B.P.A.I. 2007) »

July 18, 2007

Novocell Receives Additional Funding

     By Jason Derry --

Novocell_hdr_3 Novocell Inc. recently announced that it has received an additional $25 million in funding from a number of its stakeholders, including Johnson & Johnson Development Corp., Sanderling Ventures, Asset Management Co., and Pacific Horizon Ventures.  Novocell is located in San Diego, and focuses on stem cell research.  Its primary objective at this time is to use endoderm cells, generated from embryonic stem cells, to stimulate insulin production in diabetes patients.  According to Novocell's president and chief scientific officer, the new funding will be used in large part to move its insulin program forward in clinical development.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 09:56 AM in Biotech/Pharma Business |

Comments

The comments to this entry are closed.

November 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30    

Categories

Archives

More...